FI945198A - Farmaseuttiset ja muut annosmuodot - Google Patents

Farmaseuttiset ja muut annosmuodot Download PDF

Info

Publication number
FI945198A
FI945198A FI945198A FI945198A FI945198A FI 945198 A FI945198 A FI 945198A FI 945198 A FI945198 A FI 945198A FI 945198 A FI945198 A FI 945198A FI 945198 A FI945198 A FI 945198A
Authority
FI
Finland
Prior art keywords
pharmaceutical
dosage forms
pectin
carbon atoms
amino acids
Prior art date
Application number
FI945198A
Other languages
English (en)
Swedish (sv)
Other versions
FI945198A0 (fi
FI111333B (fi
Inventor
Dilip J Gole
Paul K Wilkinson
John Desmond Davies
R Saul Levinson
Original Assignee
Janssen Pharmaceutica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Inc filed Critical Janssen Pharmaceutica Inc
Publication of FI945198A0 publication Critical patent/FI945198A0/fi
Publication of FI945198A publication Critical patent/FI945198A/fi
Application granted granted Critical
Publication of FI111333B publication Critical patent/FI111333B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26—DRYING
    • F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B5/00—Drying solid materials or objects by processes not involving the application of heat

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI945198A 1992-05-06 1994-11-04 Kiinteä kylmäkuivattu annosmuoto ja sen valmistus FI111333B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US87975492A 1992-05-06 1992-05-06
US87975492 1992-05-06
PCT/US1993/004201 WO1993023017A1 (en) 1992-05-06 1993-05-03 Pharmaceutical and other dosage forms
US9304201 1993-05-03

Publications (3)

Publication Number Publication Date
FI945198A0 FI945198A0 (fi) 1994-11-04
FI945198A true FI945198A (fi) 1994-11-04
FI111333B FI111333B (fi) 2003-07-15

Family

ID=25374827

Family Applications (1)

Application Number Title Priority Date Filing Date
FI945198A FI111333B (fi) 1992-05-06 1994-11-04 Kiinteä kylmäkuivattu annosmuoto ja sen valmistus

Country Status (28)

Country Link
EP (1) EP0642334B1 (fi)
JP (1) JPH07508019A (fi)
KR (1) KR100194241B1 (fi)
CN (1) CN1085081A (fi)
AT (1) ATE183387T1 (fi)
BG (1) BG62681B1 (fi)
CA (1) CA2135062C (fi)
CL (1) CL2004001180A1 (fi)
CY (1) CY2175B1 (fi)
CZ (1) CZ283882B6 (fi)
DE (1) DE69326063T2 (fi)
DK (1) DK0642334T3 (fi)
ES (1) ES2136662T3 (fi)
FI (1) FI111333B (fi)
GR (1) GR3031180T3 (fi)
HK (1) HK1010693A1 (fi)
HU (2) HU227532B1 (fi)
IL (1) IL105553A (fi)
MY (1) MY112231A (fi)
NO (1) NO308065B1 (fi)
NZ (1) NZ252526A (fi)
PL (1) PL172354B1 (fi)
RO (1) RO112990B1 (fi)
RU (1) RU2131244C1 (fi)
SG (1) SG47430A1 (fi)
SK (1) SK280129B6 (fi)
TW (1) TW380053B (fi)
WO (1) WO1993023017A1 (fi)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582591A (en) * 1994-09-02 1996-12-10 Delab Delivery of solid drug compositions
US5837276A (en) * 1994-09-02 1998-11-17 Delab Apparatus for the delivery of elongate solid drug compositions
GB9504201D0 (en) * 1995-03-02 1995-04-19 Scherer Ltd R P Process for the preparation of a solid pharmaceutical dosage form
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
DE19539574A1 (de) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
FR2740686B1 (fr) * 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
BR9709907A (pt) * 1996-06-17 1999-08-10 Janssen Pharmaceutica Nv Marcacão de formas de dosagem de rápida desintegracão
TR199802616T2 (xx) * 1996-06-17 1999-03-22 Janssen Pharmaceutica N.V. �ift-konveks, h�zl� par�alanan dozaj formlar�.
KR100823524B1 (ko) * 1996-06-17 2008-11-12 얀센 파마슈티카 엔.브이. 양쪽볼록형급속붕괴제형
KR100782897B1 (ko) * 1996-06-17 2008-04-08 얀센 파마슈티카 엔.브이. 급속붕괴제형의표시방법
GB9621614D0 (en) * 1996-10-17 1996-12-11 Cultech Limited Vitamin delivery
GB9802088D0 (en) * 1998-01-30 1998-03-25 Scherer Ltd R P Pharmaceutical products
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
ES2153229T3 (es) 1998-11-11 2001-02-16 Dalli Werke Wasche Und Korperp Granulado densificado, procedimiento para su fabricacion y su utilizacion como agente desintegrador para cuerpos moldeados por compactacion.
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
FR2828380B1 (fr) * 2001-08-10 2005-07-29 Fontarome Composition a structure composite contenant des substances aromatiques et/ou des substances non aromatiques volatiles et/ou sensibles aux agents exterieurs, et son procede de fabrication
AU2003213210A1 (en) 2002-02-22 2003-09-09 Pharmacia Corporation Ophthalmic formulation with gum system
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
JPWO2004024188A1 (ja) * 2002-09-12 2006-01-05 日本メジフィジックス株式会社 薬物の血漿蛋白質結合を制御するための製剤
US20040052853A1 (en) * 2002-09-16 2004-03-18 Cp Kelco, U.S., Inc. Pectin films
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
EP2322197A2 (en) 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmaceutical compositions including low dosages of desmopressin
DE20321887U1 (de) 2003-11-10 2012-01-20 Allergan, Inc. Arzneimittel umfassend niedrige Dosierungen von Desmopressin
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
EP1797888A4 (en) 2004-09-28 2009-12-16 Senju Pharma Co OPHTHALMIC COMPOSITION CONTAINING XANTHAN GUM AND AN AMINO ACID
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005009241A1 (de) 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
JP5632162B2 (ja) * 2007-06-01 2014-11-26 協和発酵バイオ株式会社 経口組成物
BRPI0906467C1 (pt) 2008-01-25 2021-05-25 Gruenenthal Gmbh forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada
LT2273983T (lt) 2008-05-09 2016-10-25 Grünenthal GmbH Tarpinės miltelių kompozicijos gamybos būdas ir galutinė kieta dozavimo forma naudojant purškalo kietinimo stadija
EP2456427B1 (en) 2009-07-22 2015-03-04 Grünenthal GmbH Hot-melt extruded controlled release dosage form
AU2010275754B2 (en) 2009-07-22 2014-05-15 Grünenthal GmbH Tamper-resistant dosage form for oxidation-sensitive opioids
DK3254676T3 (en) * 2009-10-30 2019-03-11 Ix Biopharma Ltd QUICK-SOLVING SOLID DOSAGE FORM
MX2013002293A (es) 2010-09-02 2013-05-09 Gruenenthal Gmbh Forma de dosificacion resistente a alteracion que comprende un polimero anionico.
WO2012028319A1 (en) 2010-09-02 2012-03-08 Grünenthal GmbH Tamper resistant dosage form comprising inorganic salt
LT2736497T (lt) 2011-07-29 2017-11-10 Grünenthal GmbH Sugadinimui atspari tabletė, pasižyminti greitu vaisto atpalaidavimu
BR112014002022A2 (pt) 2011-07-29 2017-02-21 Gruenenthal Gmbh comprimido resistente à violação proporcionando liberação de fármaco imediata
US20130225697A1 (en) 2012-02-28 2013-08-29 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
AU2013248351B2 (en) 2012-04-18 2018-04-26 Grunenthal Gmbh Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
CA2907950A1 (en) 2013-05-29 2014-12-04 Grunenthal Gmbh Tamper-resistant dosage form containing one or more particles
JP6466417B2 (ja) 2013-05-29 2019-02-06 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 二峰性放出プロファイルを有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
EA032465B1 (ru) 2013-07-12 2019-05-31 Грюненталь Гмбх Защищенная от применения не по назначению пероральная фармацевтическая лекарственная форма, содержащая этиленвинилацетатный полимер, и способ ее изготовления
AU2014356581C1 (en) 2013-11-26 2020-05-28 Grunenthal Gmbh Preparation of a powdery pharmaceutical composition by means of cryo-milling
US9468606B2 (en) * 2014-03-31 2016-10-18 Johnson & Johnson Consumer Inc. Compostions and methods for enhancing the topical application of an acidic benefit agent
CN106572980A (zh) 2014-05-12 2017-04-19 格吕伦塔尔有限公司 包含他喷他多的防篡改即释胶囊制剂
CN106456550A (zh) 2014-05-26 2017-02-22 格吕伦塔尔有限公司 避免乙醇剂量倾泻的多颗粒
AU2016251854A1 (en) 2015-04-24 2017-10-19 Grunenthal Gmbh Tamper-resistant dosage form with immediate release and resistance against solvent extraction
JP2018526414A (ja) 2015-09-10 2018-09-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2166074A (en) 1937-04-09 1939-07-11 Sharp & Dohme Inc Gelatinous colloids
GB698767A (en) 1950-07-06 1953-10-21 Bayer Ag Readily soluble dry preparations of swelling substances
US2758644A (en) * 1953-07-30 1956-08-14 Virlouvet Jacques Control system for slatted roller blinds
US3234091A (en) 1955-07-08 1966-02-08 Ciba Geigy Corp Shaped medicaments and process for their manufacture
DE2017373A1 (de) 1969-04-15 1971-04-22 Orsymonde S A , Paris Lyophihsierte Produkte und Ver fahren zu ihrer Herstellung
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
CA1097233A (en) 1977-07-20 1981-03-10 George K. E. Gregory Packages
JPS5913887B2 (ja) 1979-10-30 1984-04-02 株式会社ブリヂストン 溶融金属用濾過材
DE3404382A1 (de) 1984-02-08 1985-08-14 Anton Dr. 4400 Münster Härle Saugflasche zum absaugen von sekreten aus wundhoehlen
US4697630A (en) * 1987-03-17 1987-10-06 General Clutch Corporation Tilt mechanism for venetian blinds
US5079018A (en) 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5215756A (en) 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution

Also Published As

Publication number Publication date
CY2175B1 (en) 2002-08-23
DK0642334T3 (da) 2000-04-17
HUT68224A (en) 1995-06-28
HU227532B1 (en) 2011-07-28
SK280129B6 (sk) 1999-08-06
BG99158A (bg) 1995-05-31
ATE183387T1 (de) 1999-09-15
FI945198A0 (fi) 1994-11-04
EP0642334A1 (en) 1995-03-15
NZ252526A (en) 1995-09-26
JPH07508019A (ja) 1995-09-07
CA2135062A1 (en) 1993-11-25
AU677198B2 (en) 1997-04-17
NO944207D0 (no) 1994-11-04
AU4232293A (en) 1993-12-13
CZ265494A3 (en) 1995-02-15
GR3031180T3 (en) 1999-12-31
FI111333B (fi) 2003-07-15
IL105553A (en) 1998-01-04
SG47430A1 (en) 1998-04-17
SK132094A3 (en) 1995-07-11
IL105553A0 (en) 1993-08-18
CZ283882B6 (cs) 1998-06-17
TW380053B (en) 2000-01-21
CL2004001180A1 (es) 2005-06-03
DE69326063T2 (de) 2000-03-16
MY112231A (en) 2001-05-31
KR950700728A (ko) 1995-02-20
HU211549A9 (en) 1995-12-28
RU2131244C1 (ru) 1999-06-10
PL172354B1 (pl) 1997-09-30
KR100194241B1 (ko) 1999-06-15
CA2135062C (en) 1999-05-25
NO308065B1 (no) 2000-07-17
WO1993023017A1 (en) 1993-11-25
NO944207L (no) 1994-11-04
CN1085081A (zh) 1994-04-13
RO112990B1 (ro) 1998-03-30
RU94046029A (ru) 1996-11-10
ES2136662T3 (es) 1999-12-01
HK1010693A1 (en) 1999-06-25
BG62681B1 (bg) 2000-05-31
DE69326063D1 (de) 1999-09-23
EP0642334B1 (en) 1999-08-18

Similar Documents

Publication Publication Date Title
FI945198A (fi) Farmaseuttiset ja muut annosmuodot
MX9206851A (es) Sales organicas de n,n'-diacetil cistina, proceso para su preparacion y composicion farmaceutica que las contiene.
AR042345A2 (es) Un procedimiento para la preparacion de una composicion farmaceutica para el tratamiento de aterosclerosis que contiene 8.9 - dehidroesterona o sus sales de la misma
ATE74003T1 (de) Waessriges pharmazeutisches praeparat.
SE9002522L (sv) Metod foer framstaellning av en farmaceutisk komposition i form av mikropartiklar
DE68925898D1 (de) Grossflächige uniforme elektronenquelle
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
DE19375061I2 (de) Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
DE69119810D1 (de) Pyrogensorbentmittel
ES2062292T3 (es) Un proceso para la preparacion del compuesto que tiene la estructura (7alfa,17alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-in-3-ona.
ES2056153T3 (es) Expectorante que comprende un derivado hidroxialquilcisteina.
ATE78166T1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
KR910007531A (ko) 15-케토-프로스타글란딘 화합물을 이용한 간 담즙성 질병의 치료
MX9102087A (es) Complejos que contienen acidos s(+) fenilalcanos y acidos alfa-hidroxi alcanos.
IT1224250B (it) Associzione del depiprazolo con la morfina
IT8921600A0 (it) Derivati 4 amminofenilici cicloalchil sostituiti e processo per la loro preparazione.
ATE80143T1 (de) Isomere formyl-trimethylbicyclo(2,2,2)oct-7-ene.
DK0741746T3 (da) Thymosin alpha 1-analoger
IT8705155A0 (it) Metodo per la costruzione di calze a punta chiusa su macchine circolari da calzetteria e calza ottenuta.
ITMI921084A1 (it) Struttura di macchina da cucire perfezionata, particolarmente studiata per la cucitura di calzature e simili
FI894347A0 (fi) 2,3,4,5-tetrahydro-1-benzoxepiner, foerfarande foer deras framstaellning, deras anvaendning och dessa foereningar innehaollande farmaceutiska preparat.
MX9203430A (es) Medicamento que contiene ibuprofen.
FR2697968B1 (fr) Variété de Pinus Nigra nain.
RU93058659A (ru) Способ снижения побочных эффектов лекарства

Legal Events

Date Code Title Description
MA Patent expired